| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/26/2002 | US20020137136 Culture product |
| 09/26/2002 | US20020137135 Novel NPG-1 gene that is differentially expressed in prostate tumors |
| 09/26/2002 | US20020137133 Receptor proteins |
| 09/26/2002 | US20020137132 Genetic engineering; diagnosis of psychological disorders |
| 09/26/2002 | US20020137131 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/26/2002 | US20020137130 Central nervous system disorder |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137128 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137126 Al-1 neurotrophic factor, a ligand for an eph related tyrosine kinase receptor |
| 09/26/2002 | US20020137119 Immunoassay; quantitative analysis |
| 09/26/2002 | US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same |
| 09/26/2002 | US20020137113 Kinase receptor activation assay |
| 09/26/2002 | US20020137112 Monitoring using adduct of amyloid protein modified with malonaldehyde |
| 09/26/2002 | US20020137111 Chlamydia heat shock protein |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137107 Method for identifying agents which modulate chemokine "MEC"-induced functions of CCR3 and/or CCR10 |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137092 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto- immune antibodies |
| 09/26/2002 | US20020137077 Diagnosis, therapy monitoring allergies, infections, cancer, autoimmune disease |
| 09/26/2002 | US20020137063 Diagnosis, therapy of metabolism disorders; polymerase chain reaction |
| 09/26/2002 | US20020137054 AXOR35, a G-protein coupled receptor |
| 09/26/2002 | US20020137051 Detecting mutant genes |
| 09/26/2002 | US20020137050 Hybrid Dna sequence |
| 09/26/2002 | US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto |
| 09/26/2002 | US20020137040 Polymorphism in p21 waf1/cip1 gene, association with human cancer and uses related thereto |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020137035 Hybrid analyzing; tuberculosis diagnosis |
| 09/26/2002 | US20020137030 Method of detection of neoplastic cells |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020137023 Methods and compositions for targeting compounds to muscle |
| 09/26/2002 | US20020137020 Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2 |
| 09/26/2002 | US20020137019 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 09/26/2002 | US20020136742 Outer membrane protein polypeptide lacking regions VD1 and VD2 |
| 09/26/2002 | US20020136741 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 09/26/2002 | US20020136740 With an antigen that has an epitope of hepatitis c virus |
| 09/26/2002 | US20020136739 Subunit respiratory syncytial virus preparation |
| 09/26/2002 | US20020136737 Isolated nucleic acids comprising Listeria dal and dat genes |
| 09/26/2002 | US20020136736 Or prophylactically or therapeutically effective fragment thereof in admixture with a pharmaceutically acceptable carrier |
| 09/26/2002 | US20020136734 Vaccines for the protection of cattle from psoroptic scabies |
| 09/26/2002 | US20020136733 From Plasmodium falciparum antigens, circumsporozoite protein, thrombospondin-related anonymous protein,spirozoite hepatocyte binding antigen,liver-stage antigen-1; cytotoxic T lymphocyte epitopes for human leucocyte antigens; malaria vaccine |
| 09/26/2002 | US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136724 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 09/26/2002 | US20020136722 Adjuvants comprising CD40 ligands crosslinked to antigens, wherein the adjuvants have reduced toxicity and adjuvants comprising CD40 ligands crosslinked to viral antigens |
| 09/26/2002 | US20020136720 Methods of using IMXP-888 and IMXP-888 antagonists |
| 09/26/2002 | US20020136717 Process for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1 binding domain or a protein having an EVH1 binding domain, and a process for detecting said interaction |
| 09/26/2002 | US20020136716 Compositions and methods for altering cell migration |
| 09/26/2002 | US20020136714 Relatedness of human interleukin-1beta convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor |
| 09/26/2002 | US20020136707 Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 09/26/2002 | US20020136689 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds |
| 09/26/2002 | DE10113042A1 Identifying compounds that modify interaction of gp120 and co-receptors, useful potentially for treating human immune deficiency virus infection, also new peptides |
| 09/26/2002 | DE10110235A1 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
| 09/26/2002 | CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2442036A1 Stress-responsive activator of p300 (strap) protein |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441815A1 Method and composition for treatment of skeletal dysplasias |
| 09/26/2002 | CA2441740A1 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | CA2441564A1 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441503A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | CA2441388A1 Modified insulin with reduced immunogenicity |
| 09/26/2002 | CA2441339A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/26/2002 | CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | CA2441275A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | CA2441265A1 Sugar and lipid metabolism regulators in plants |
| 09/26/2002 | CA2441233A1 Cell cycle nucleic acids, polypeptides and uses thereof |
| 09/26/2002 | CA2441165A1 Use of binding domains of presenilins and transmembrane proteins for drug screening |
| 09/26/2002 | CA2441147A1 Methods of treating disorders of the eye and surrounding tissue with thymosin .beta.4 (t.beta.4), analogues, isoforms and other derivatives |
| 09/26/2002 | CA2441095A1 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | CA2440859A1 Transgenic animal model of ige-mediated allergic responses |
| 09/26/2002 | CA2440747A1 Novel nucleic acids and polypeptides |
| 09/26/2002 | CA2440584A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2439532A1 Methods and reagents for regulating apoptosis |
| 09/26/2002 | CA2439315A1 Compositions useful in gene therapy |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2438308A1 Peg-conjugates of hgf-nk4 |
| 09/26/2002 | CA2438279A1 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/26/2002 | CA2435000A1 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
| 09/25/2002 | EP1243928A1 Means of stabilizing compositions and reagents |
| 09/25/2002 | EP1243923A1 METHOD OF SCREENING REMEDY FOR CANCER WITH THE USE OF INTERACTION DOMAINS OF p53 AND MORTALIN |
| 09/25/2002 | EP1243660A2 Human udp-Galnac:polypeptide n-acetylgalatosaminyltransferase 10 |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1243654A1 Precursor polypeptides of phytosulfokine derived from Arabidopsis thaliana and cDNAs encoding said polypeptides |
| 09/25/2002 | EP1243653A2 E25a protein, methods for producing and use thereof |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243651A1 Method of detecting sexual differentiation disruptor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243648A1 Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and uses thereof |
| 09/25/2002 | EP1243646A2 Transgenic Drosophila with human APC gene for pharmacological screenings |
| 09/25/2002 | EP1243645A1 Penicillin production using transgenic merodiploid strains |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |